INZY
Inozyme Pharma
INZY
INZY
Delisted
INZY was delisted on the 30th of June, 2025.
50 hedge funds and large institutions have $71.2M invested in Inozyme Pharma in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 13 increasing their positions, 17 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
24% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 17
40% less capital invested
Capital invested by funds: $118M → $71.2M (-$47M)
Holders
50
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.61M | |
| 2 | +$1.33M | |
| 3 | +$604K | |
| 4 |
BlackRock
New York
|
+$169K |
| 5 |
Renaissance Technologies
New York
|
+$49K |
Top Sellers
| 1 | -$3.59M | |
| 2 | -$771K | |
| 3 | -$606K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$247K |
| 5 |
Millennium Management
New York
|
-$136K |